Contact
Please use this form to send email to PR contact of this press release:
PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024
TO:
Please use this form to send email to PR contact of this press release:
PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024
TO: